<--- Back to Details
First PageDocument Content
Neurochemistry / Chemistry / Nervous system / Euphoriants / Morphinans / Phenols / GABAA receptor positive allosteric modulators / Ethers / Buprenorphine / Opioid / Methadone / Analgesic
Date: 2015-12-08 07:37:32
Neurochemistry
Chemistry
Nervous system
Euphoriants
Morphinans
Phenols
GABAA receptor positive allosteric modulators
Ethers
Buprenorphine
Opioid
Methadone
Analgesic

HIGHLIGHTS OF PRESCRIBING INFORMATION • Do not abruptly discontinue BELBUCA in a physically dependent patient. These highlights do not include all the information needed to use BELBUCA safely and effectively. See full

Add to Reading List

Source URL: www.endo.com

Download Document from Source Website

File Size: 614,12 KB

Share Document on Facebook

Similar Documents

CLIENT  BULLETIN Measuring Buprenorphine and Norbuprenorphine in Urine Buprenorphine is used as a replacement therapy in the treatment of opioid dependence and as an analgesic. This medication also has the potential for

CLIENT BULLETIN Measuring Buprenorphine and Norbuprenorphine in Urine Buprenorphine is used as a replacement therapy in the treatment of opioid dependence and as an analgesic. This medication also has the potential for

DocID: 1vgU3 - View Document

MEDTOX® BUPRENORPHINE MEDTOX® Buprenorphine is a rapid qualitative screening test for buprenorphine and its metabolites in human urine. 1. INTENDED USE The MEDTOX Buprenorphine Test uses immunochromatographic test stri

MEDTOX® BUPRENORPHINE MEDTOX® Buprenorphine is a rapid qualitative screening test for buprenorphine and its metabolites in human urine. 1. INTENDED USE The MEDTOX Buprenorphine Test uses immunochromatographic test stri

DocID: 1v9Pg - View Document

SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII)  Talking with your doctor Opioid dependence can be treated. Talking with your healthcare team keeps them aware of your situation so they may adjust your trea

SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII) Talking with your doctor Opioid dependence can be treated. Talking with your healthcare team keeps them aware of your situation so they may adjust your trea

DocID: 1uBp8 - View Document

Authorization Expanded to Qualified Certified Nurse Practitioners for the Prescribing of Buprenorphine to Treat Opioid Addiction The Comprehensive Addiction and Recovery Act (CARA) was signed into law on July 22, 2016. O

Authorization Expanded to Qualified Certified Nurse Practitioners for the Prescribing of Buprenorphine to Treat Opioid Addiction The Comprehensive Addiction and Recovery Act (CARA) was signed into law on July 22, 2016. O

DocID: 1tRGm - View Document

ATION ASSISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MEDICATION ASSISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MED  SISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MEDICATION ASSISTED TREATMENT• BUPRENOR

ATION ASSISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MEDICATION ASSISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MED SISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MEDICATION ASSISTED TREATMENT• BUPRENOR

DocID: 1tG05 - View Document